Interstate Medical Licensure Compact Sails Through Senate Committee > Hospital Association of Pennsylvania

HAP

Login to view your account.

Don't have an account? Click here.

Newsroom

Interstate Medical Licensure Compact Sails Through Senate Committee

June 29, 2016

The Senate Consumer Protection and Professional Licensure Committee voted, with ease, House Bill 1619 out of committee unanimously today. Known as the Interstate Medical Licensure Compact sponsored by Rep. Jesse Topper (R-Bedford), House Bill 1619 enables Pennsylvania to join a compact that already includes 16 other states. The compact allows eligible licensed physicians in one state to treat patients in other states via telehealth and streamlines the licensing process for physicians looking to practice in the state.

HAP supports this legislation:

  • It is an important first step towards modernizing physician licensing and keeping up with the constantly advancing technology in health care, telehealth
  • House Bill 1619 will ensure an eligible physician’s license is portable while ensuring all of the key protections that Pennsylvania’s own licensure process provides for patients
  • This legislation will allow for the increased access to essential medical care for underserved areas by connecting individuals with specialists, not just in rural areas, but also urban

“This compact has applicability in, and will affect, every part of the commonwealth,” said Andy Carter, HAP President and CEO. “Pennsylvania can set an example for other states by joining the interstate compact so that everyone has access to great medical care in a timely fashion. We hope to see this legislation reach the Governor’s desk in the near future.”

The compact would be administered and enforced by an interstate commission which would include representatives from the commonwealth. This commission would grant an expedited license to an eligible physician licensed in another state so long as they are already certified in a medical specialty, and have no prior record of being penalized by the courts, medical licensing agency, or the U.S. Drug Enforcement Agency.

The bill now awaits consideration of the full Senate.

Questions may be directed to Stephanie Watkins, HAP’s vice president, state legislative advocacy.

« Close